A Pseudomonas aeruginosa-Derived Particulate Vaccine Protects against P. aeruginosa Infection

Despite numerous efforts to develop an effective vaccine against Pseudomonas aeruginosa, no vaccine has yet been approved for human use. This study investigates the utility of the P. aeruginosa inherently produced polyhydroxyalkanaote (PHA) inclusions and associated host–cell proteins (HCP) as a par...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzaga, Zennia Jean C., Merakou, Christina, DiGiandomenico, Antonio, Priebe, Gregory P., Rehm, Bernd H. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309987/
https://www.ncbi.nlm.nih.gov/pubmed/34358220
http://dx.doi.org/10.3390/vaccines9070803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309987/
https://www.ncbi.nlm.nih.gov/pubmed/34358220
http://dx.doi.org/10.3390/vaccines9070803

Ejemplares similares